» Authors » Fernando Soler

Fernando Soler

Explore the profile of Fernando Soler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 135
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lax A, Soler F, Fernandez Del Palacio M, Pascual-Oliver S, Ballester M, Fuster J, et al.
Mol Ther Nucleic Acids . 2023 May; 32:704-720. PMID: 37234747
Clinical use of doxorubicin (Dox), an anthracycline with potent anti-tumor effects, is limited because of its highly chemotherapy-induced cardiotoxicity (CIC). After myocardial infarction (MI), we have recently identified Yin Yang-1...
2.
Sanchez-Camara S, Asensio-Lopez M, Royo-Villanova M, Soler F, Jara-Rubio R, Garrido-Penalver J, et al.
Am J Transplant . 2022 Feb; 22(5):1321-1328. PMID: 35114047
Donation after circulatory death (DCD) represents a promising opportunity to overcome the relative shortage of donors for heart transplantation. However, the necessary period of warm ischemia is a concern. This...
3.
Asensio-Lopez M, Sassi Y, Soler F, Fernandez Del Palacio M, Pascual-Figal D, Lax A
Sci Rep . 2021 Feb; 11(1):3915. PMID: 33594087
Left ventricular remodeling following myocardial infarction (MI) is related to adverse outcome. It has been shown that an up-regulation of plasma soluble ST2 (sST2) levels are associated with lower pre-discharge...
4.
Soler F, Sanchez-Garcia A, Molina-Martin A, de Fez D, Diaz V, Pinero D
Curr Eye Res . 2021 Jan; 46(8):1240-1246. PMID: 33406917
Purpose: To analyze and characterize the pattern of visual working distance (WD) and mobile phone usage distance (MPD) in a large population, analyzing the differences in these parameters according to...
5.
Gomez-Banoy N, Cuevas V, Soler F, Pineda M, Mockus I
Arch Endocrinol Metab . 2017 Jul; 61(5):470-475. PMID: 28724059
Objective: This cross sectional study intended to evaluate two bedside tests (Neuropad and VibraTip) as screening tools for distal symmetrical polyneuropathy (DSPN) in Latin American patients with type 2 diabetes...
6.
Asensio-Lopez M, Soler F, Pascual-Figal D, Fernandez-Belda F, Lax A
PLoS One . 2017 Mar; 12(2):e0172803. PMID: 28245258
The primary cardiotoxic action of doxorubicin when used as antitumor drug is attributed to the generation of reactive oxygen species (ROS) therefore effective cardioprotection therapies are needed. In this sense,...
7.
Asensio-Lopez M, Soler F, Sanchez-Mas J, Pascual-Figal D, Fernandez-Belda F, Lax A
Arch Biochem Biophys . 2016 Feb; 594:26-36. PMID: 26906075
In atrial-derived HL-1 cells, ryanodine receptor and Na(+)/Ca(2+)-exchanger were altered early by 5 μM doxorubicin. The observed effects were an increase of cytosolic Ca(2+) at rest, ensuing ryanodine receptor phosphorylation,...
8.
Soler F, Fernandez-Belda F, Perez-Schindler J, Hernandez-Cascales J
Eur J Pharmacol . 2015 Sep; 765:429-36. PMID: 26364538
Cyclic nucleotide phosphodiesterase (PDE)3 and PDE4 provide the major PDE activity in cardiac myocytes and shape β1-adrenoceptor-dependent cardiac cAMP signaling but their role in regulating β2-adrenoceptor-mediated responses is less well...
9.
Soler F, Fernandez-Belda F, Perez-Schindler J, Handschin C, Fuente T, Hernandez-Cascales J
Exp Biol Med (Maywood) . 2014 Nov; 240(9):1205-13. PMID: 25432985
The important regulator of cardiac function, cAMP, is hydrolyzed by different cyclic nucleotide phosphodiesterases (PDEs), whose expression and activity are not uniform throughout the heart. Of these enzymes, PDE2 shapes...
10.
Coca R, Soler F, Cortes-Castell E, Gil-Guillen V, Fernandez-Belda F
PLoS One . 2014 Jul; 9(7):e102083. PMID: 25003576
Dimethyl-celecoxib is a celecoxib analog that lacks the capacity as cyclo-oxygenase-2 inhibitor and therefore the life-threatening effects but retains the antineoplastic properties. The action mechanism at the molecular level is...